Alphatec Holdings Reports Strong Preliminary 2025 Results and 2026 Outlook
Alphatec Holdings announced preliminary 2025 financial results on January 12, showing 25% revenue growth and providing a 2026 outlook. The company also entered a strategic agreement with Theradaptive for exclusive U.S. distribution rights to OsteoAdapt.